TY - JOUR
T1 - Aging and oral squamous cell carcinoma development
T2 - the role of cellular senescence
AU - Niklander, Sven Eric
AU - Aránguiz, Pablo
AU - Faunes, Fernando
AU - Martínez-Flores, René
N1 - Publisher Copyright:
2023 Niklander, Aránguiz, Faunes and Martínez-Flores.
PY - 2023
Y1 - 2023
N2 - The gradual accumulation and inadequate renewal of senescent cells over time drive organismal aging. Senescent cells undergo altered gene expression and release inflammatory mediators collectively termed the senescence-associated secretory phenotype (SASP), which significantly contributes to a spectrum of age-related disorders, including cancer. In the context of carcinogenesis, the SASP produced by senescent cells has been implicated in the promotion of epithelial cancers, including oral squamous cell carcinoma (OSCC), the most common form of oral cancer. Senescent cells within the tumor microenvironment release factors that amplify the growth and invasiveness of neighboring cancer cells. Senotherapeutics, including senolytics and senomorphics, emerge as promising modalities to target senescent cells and their associated inflammatory factors, thereby opening novel avenues for augmenting the efficacy of cancer treatments. Here, we review the general aspects of cellular senescence, focusing on the relation between senescence-related inflammation with cancer development. We also analyze the available evidence linking cellular senescence with OSCC, highlighting possible clinical applications.
AB - The gradual accumulation and inadequate renewal of senescent cells over time drive organismal aging. Senescent cells undergo altered gene expression and release inflammatory mediators collectively termed the senescence-associated secretory phenotype (SASP), which significantly contributes to a spectrum of age-related disorders, including cancer. In the context of carcinogenesis, the SASP produced by senescent cells has been implicated in the promotion of epithelial cancers, including oral squamous cell carcinoma (OSCC), the most common form of oral cancer. Senescent cells within the tumor microenvironment release factors that amplify the growth and invasiveness of neighboring cancer cells. Senotherapeutics, including senolytics and senomorphics, emerge as promising modalities to target senescent cells and their associated inflammatory factors, thereby opening novel avenues for augmenting the efficacy of cancer treatments. Here, we review the general aspects of cellular senescence, focusing on the relation between senescence-related inflammation with cancer development. We also analyze the available evidence linking cellular senescence with OSCC, highlighting possible clinical applications.
KW - cellular senescence
KW - mouth neoplasm
KW - oral cancer
KW - oral potentially malignant disorder
KW - SASP
KW - senotherapeutics
UR - http://www.scopus.com/inward/record.url?scp=85174936494&partnerID=8YFLogxK
U2 - 10.3389/froh.2023.1285276
DO - 10.3389/froh.2023.1285276
M3 - Review article
AN - SCOPUS:85174936494
SN - 2673-4842
VL - 4
JO - Frontiers in Oral Health
JF - Frontiers in Oral Health
M1 - 1285276
ER -